Good News for Humankind
Your daily spark of possibility
The world is changing — for the better, and in real, indisputable ways. Climate breakthroughs. Justice wins. Scientific discoveries. From people you’ve never heard of. In places you wouldn’t expect.
Every weekday, I send a piece of good news from around the world — not to sugarcoat reality, but to remind you that change is possible.
Every weekday morning at 7am. Or sign up for the weekly digest.
What Readers Are Saying
It restores my faith that homo sapiens sapiens, even if not in everything and always, deserves the name it has given itself.
Peter is all passion. He’s spent years working toward the greater good by helping his readership and community becoming the best version of themselves. His thoughtfully curated positive news stories stem from his genuine and effortless capacity to empathize. You’re an inspiration, Peter. Thank you!
Good News daily restores my faith in humanity and in Universal Source; I’ve shared this newsletter with family and friends and we love it! Hurray for Peter’s inspiration and generosity! So grateful.
I forward this to friends who need a remedy for despair.
Good News for Humankind has been a crack of light in my inbox for years because it provides a some counter balance to the dystopian info-tsunami that passes for news from other sources.
The Latest Good News
Topic All #Resist Abortion rights & access Activism & Protests Agriculture Air pollution Animal husbandry & domestication Animal rights & well-being Architecture & design Artificial intelligence Arts, music, literature & entertainment Astronomy & space exploration Athletics & sport Black Lives Matter Blockchain & cryptocurrency Capital punishment Caste abolition Child well-being Circular economy & zero waste Cities Civilization Clean & renewable energy Climate crisis Clothing Colonialism Communication & language Conscious management Consumer rights & well-being Corporate responsibility COVID-19 Crime Culture Death & Grief Debt Decolonization Democracy & voting Disabilities & special needs Discovery & exploration Drinking water; sanitation & hygiene Drugs & Entheogens Economic inequality Education Elections Electrification Environment Ethical sourcing Ethics Evolution Finance Flora & fauna Food & diet Free speech & censorship Fresh water conservation Gay rights Gender Genocide Government Green bonds Gun safety Hate speech Healthcare Houselessness Human rights Immigration Independence Indigenous rights & well-being Infrastructure International cooperation Internet rights Journalism Justice system Kingdoms & empire Law LGBTQ+ rights & well-being Life expectancy & mortality Literature Local resilience Marine conservation Medicine Men's health & well-being Mental health & addiction Migration & settlement Military Mindfulness & self-care Minimum wage Mythology & folklore Nations Natural gas & divestment News & media No coal No fracking Nuclear disarmament Numbers & math Ocean health Oil Oil, natural gas & divestment Parenting Paris Agreement Peace Philanthropy Philosophy Physics Plastic pollution Police reform Pollution Poverty alleviation Prison justice Privacy & security Public health & disease Public safety Racial justice Refugees Religion Reparations Reproductive rights Revolution Rights of nature Same-sex marriage Seniors' rights & well-being Sexual assault & domestic violence Shamanism & rituals Social media Sustainability Sustainable Development Goals Technology & innovation Tourism Trade Transgender rights & well-being Transportation Trees & reforestation Universal basic income Water pollution Wildlife & land conservation Women's rights & well-being Workers' rights & well-being Youth & student movements
Country All Afghanistan Albania Algeria Andorra Angola Antigua and Barbuda Argentina Armenia Australia Austria Azerbaijan Bangladesh Barbados Belgium Belize Benin Bermuda Bhutan Bolivia Bosnia-Herzegovina Botswana Brazil Brunei Bulgaria Burkina Faso Burundi Cambodia Cameroon Canada Cape Verde Chad Cherokee Nation Chile China Colombia Congo Cook Islands Costa Rica Croatia Cuba Cyprus Czech Republic Democratic Republic of Congo Denmark Djibouti Dominica Dominican Republic Ecuador Egypt El Salvador England Equatorial Guinea Eritrea Estonia Ethiopia European Union Faroe Islands Federated States of Micronesia Fiji Finland France French Polynesia Gabon Georgia Germany Ghana Greece Greenland Grenada Guadaloupe Guatemala Guyana Honduras Hong Kong Hungary Iceland India Indonesia Iran Iraq Ireland Israel Italy Jamaica Japan Jordan Kazakhstan Kenya Kiribati Kosovo Kuwait Laos Latvia Lebanon Lesotho Liberia Libya Lithuania Luxembourg Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Martinique Mauritania Mauritius Mexico Micronesia Moldova Monaco Mongolia Montenegro Montserrat Morocco Mozambique Myanmar Namibia Nauru Nepal New Caledonia New Zealand / Aotearoa Nicaragua Niger Nigeria Niue North Korea North Macedonia Northern Ireland Norway Oman Pakistan Palau Palestine Panama Papua New Guinea Paraguay Peru Poland Portugal Qatar Romania Russia Rwanda Samoa San Marino Sao Tome and Principe Saudi Arabia Scotland Senegal Serbia Seychelles Sierra Leone Singapore Slovakia Slovenia Solomon Islands Somalia South Africa South America South Korea South Sudan Soviet Union Spain Sri Lanka St. Kitts & Nevis St. Lucia St. Vincent and the Grenadines Sudan Suriname Sweden Switzerland Syria Taiwan Tanzania Thailand The Bahamas The Gambia The Netherlands The Philippines Timor Leste Togo Tokelau Tonga Trinidad & Tobago Tristan da Cunha Tunisia Turkey Turkmenistan Tuvalu Uganda Ukraine United Arab Emirates United Kingdom United States Uruguay Uzbekistan Vanuatu Vatican City Venezuela Vietnam Wales Yemen Zambia Zimbabwe
Actor All Activists Artists & philosophers Athletes Business Cities Citizens Civil society Consumers Courts Early humans Engineers Finance Humanity Humankind Indigenous groups International organizations Inventors Kingdoms & empires Media & Journalists Military Nations Non-humans Regions Religious groups Science & academia Scientists & mathematicians Settlers & explorers States & provinces Utilities Workers World leaders
2024 C.E.
October 8
Lead pipes in roughly nine million American homes are now on a federal clock: the EPA's new rule requires every utility to find and replace them within 10 years. Backed by $2.6 billion in fresh funding, the policy marks a dramatic shift from previous timelines that stretched 40 or even 50 years out. Nearly half the money is directed to disadvantaged communities, where decades of disinvestment left lead lines in place long after wealthier...
2024 C.E.
October 7
Australia's ocean protection just leveled up in a big way, with a sub-Antarctic marine reserve quadrupling to add 300,000 square kilometers of safeguarded waters — an area roughly the size of Italy. The expansion around Heard and McDonald Islands shields glaciers, albatross, macaroni penguins, elephant seals, and fish found almost nowhere else, keeping mining and new commercial fisheries out of one of the planet's least-disturbed places. With this move, Australia now protects 52% of...
2024 C.E.
October 7
Lenacapavir, a twice-yearly HIV prevention shot with near-perfect results in clinical trials, is about to become far more affordable for millions of people. Gilead Sciences has licensed six generic manufacturers across India, Egypt, Pakistan, and the U.S. to produce the drug for 120 lower-income countries, where researchers estimate it could eventually be made for as little as $40 per patient per year. In trials among cisgender women in South Africa and Uganda, not a...
2024 C.E.
October 5
The first mpox diagnostic test has been cleared through the World Health Organization's Emergency Use Listing, opening a faster procurement route for the countries hit hardest by the outbreak. Abbott's Alinity m MPXV assay detects both clades of the virus from rash samples, and UN agencies can now order it directly for places where national approval pathways would otherwise take months. That speed matters: in 2024, only 37% of suspected mpox cases in the...
2024 C.E.
October 4
OvarianVax, in development at the University of Oxford, has just received up to £600,000 from Cancer Research U.K. to pursue the world's first vaccine designed to prevent ovarian cancer before it begins. The idea is to train the immune system to recognize over 100 proteins found on early-stage ovarian cancer cells, then destroy those cells before they can spread. For women carrying BRCA gene mutations, who currently face the wrenching choice of preventive surgery...
Load More
Enjoying these stories? Get one delivered to your inbox every weekday morning — free.
Go to good news archives for specific countries, institutions, topics, etc.